Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Identifying imaging biomarkers in brain and spinal cord to detect disease progression in multiple sclerosis

EF 2017-18

Résumé
Currently, there are no approved treatments for progressive multiple sclerosis (MS) in Canada. Past clinical trials have largely been unsuccessful as clinical measures of progression change slowly thus, requiring a large trial population and long follow-up time to observe treatment effects. While active lesions seen using magnetic resonance imaging (MRI) provide a valuable outcome measure of disease-related damage in clinical trials for relapsing MS, they have been less suitable for progressive MS. Thus, imaging markers of disease progression represent an urgent and unmet need in the development of progressive MS treatment. Advanced MRI that can quantitatively measure myelin content (the insulating coating around brain and spinal cord cells that is damaged in MS) may overcome this challenge. We will investigate myelin and tissue loss in brain and spinal cord of progressive MS in vivo , and correlate with clinical measures. With this work, we hope to establish imaging markers that reflect underlying pathological changes responsible for clinical disability. Such imaging markers will ultimately improve the quality of life of people with progressive MS by allowing for more efficient clinical trials to establish effective treatment options, identifying patients at risk for severe progression, and informing treatment decisions.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
386344
Name
Lee Eun Young
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying imaging biomarkers in brain and spinal cord to detect disease progression in multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atrophy; Brain; Disease Progression; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin Biology; Myelin Water Imaging; Neuropathology; Quantitative Imaging; Spinal Cord
Abstract
Currently, there are no approved treatments for progressive multiple sclerosis (MS) in Canada. Past clinical trials have largely been unsuccessful as clinical measures of progression change slowly thus, requiring a large trial population and long follow-up time to observe treatment effects. While active lesions seen using magnetic resonance imaging (MRI) provide a valuable outcome measure of disease-related damage in clinical trials for relapsing MS, they have been less suitable for progressive MS. Thus, imaging markers of disease progression represent an urgent and unmet need in the development of progressive MS treatment. Advanced MRI that can quantitatively measure myelin content (the insulating coating around brain and spinal cord cells that is damaged in MS) may overcome this challenge. We will investigate myelin and tissue loss in brain and spinal cord of progressive MS in vivo , and correlate with clinical measures. With this work, we hope to establish imaging markers that reflect underlying pathological changes responsible for clinical disability. Such imaging markers will ultimately improve the quality of life of people with progressive MS by allowing for more efficient clinical trials to establish effective treatment options, identifying patients at risk for severe progression, and informing treatment decisions.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Eun Young
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~